RxDoctor Payments DataLook up a doctor →

Jacob Witt, MD

Radiation Oncology · O Fallon, ILNPI 1891157871

Payments from drug & device makers

$10,083in general payments, 2019–2025

Across 466 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Merck$802
  • Johnson & Johnson$650
  • AstraZeneca$606
  • Raysearch Laboratories AB (publ)$485
  • Incyte Corporation$479
  • plus $6K from 54 others

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis62$1,201
Merck40$802
Johnson & Johnson32$650
AstraZeneca(2 entities)29$606
Raysearch Laboratories AB (publ)1$485
Incyte Corporation29$479
Takeda Pharmaceuticals U.S.A., Inc.19$467
AbbVie17$388
Pfizer20$343
Bayer17$336
Amgen13$316
Jazz Pharmaceuticals Inc.10$279
Regeneron Healthcare Solutions, Inc.11$266
Daiichi Sankyo Inc.10$241
Stemline Therapeutics Inc.10$222
Lilly USA, LLC11$192
EMD Serono, Inc.7$191
Sobi, Inc8$169
Genentech USA, Inc.7$151
Seagen Inc.7$150
Exelixis Inc.6$148
Genmab U.S., Inc.6$142
Sanofi6$140
Coherus Oncology, Inc.7$139
Rigel Pharmaceuticals, Inc.7$108
Penumbra, Inc.1$107
Adaptive Biotechnologies Corporation4$73
Eisai Inc.4$72
AVEO Pharmaceuticals, Inc.4$71
Novocure Inc.4$69
Astellas Pharma US Inc3$68
Taiho Oncology, Inc.4$64
Boehringer Ingelheim3$63
Servier Pharmaceuticals LLC3$63
Blueprint Medicines Corporation3$59
G1 Therapeutics, Inc.3$57
Morphosys, US Inc.3$53
Immunocore Limited2$51
Mirati Therapeutics, Inc.3$47
Amneal Pharmaceuticals LLC2$46
Tersera Therapeutics LLC2$37
GSK2$36
Tolmar, Inc.2$32
Tactile Systems Technology Inc2$31
ADC Therapeutics America, Inc.2$28
Beigene USA, Inc.1$26
Pharmacyclics LLC, An Abbvie Company1$24
Tempus AI, Inc1$23
Clovis Oncology, Inc.1$23
Pharmaessentia USA Corporation1$22
Geron Corporation1$22
Beone Medicines USA, Inc.1$21
Siemens Medical Solutions USA, Inc.1$20
Syndax Pharmaceuticals, Inc.1$19
Spectrum Pharmaceuticals Inc.1$19
Agios Pharmaceuticals, Inc.1$19
Pharmacosmos Therapeutics Inc.1$18
Karyopharm Therapeutics Inc.1$17
Accord Healthcare, Inc.1$16
Gilead1$15

How this compares

$10,083 in reported general payments places this provider in the 85th percentile of 242 radiation oncology providers in Illinois.

See all radiation oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$683,054
Medicare patients
256
Services billed
11,139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in O Fallon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →